Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Earnings callYahoo Finance· February 4, 2026

Gladstone Investment Q3 Earnings Call Highlights

View original at finance.yahoo.com
Gladstone Investment Q3 Earnings Call Highlights Gladstone Investment logo Gladstone Investment (NASDAQ:GAIN) reported results for its fiscal third quarter ended Dec…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The company began the prior fiscal year with $55.3 million of spillover income (about $1.50 per share), which supported the regular monthly distribution and a $0.54 per share supplemental distribution paid in June

    80% confidence
  • The M&A market is liquid and competitive, with valuations that can be challenging, but the company remains disciplined in underwriting and continues to pursue both new platform investments and add-on acquisitions for existing portfolio companies

    80% confidence
  • The firm's strategy typically involves becoming the majority economic owner while financing acquisitions with a mix of equity and debt—equity for potential capital gains at exit and debt to generate recurring income to support shareholder distributions

    80% confidence
  • The redemption of 8% notes and issuance of 6.875% notes reduced the interest burden for approximately $75 million of debt capital by about 110 basis points

    80% confidence
  • Management feels better about the non-accrual names than a year ago, citing actions being taken and noting the companies are generating positive EBITDA, though structural issues remain before a return to accrual status

    80% confidence
  • Notable NAV appreciation in certain investments was attributed to EBITDA growth rather than multiple expansion, including for Schylling, Old World Christmas, and SFE-SFEG

    80% confidence
  • Reaching the portfolio-wide floor would require a significant drop in SOFR, requiring roughly 210 basis points of additional SOFR declines for more investments to hit their floors

    80% confidence
  • The decline in total investment income was attributed primarily to lower dividend and success fee income, partially offset by higher interest income as the debt investment portfolio grew

    80% confidence
  • Supplemental distributions are expected to remain part of the shareholder return strategy, with timing and amounts driven by realized capital gains and other capital allocation considerations

    80% confidence
  • New debt investments are being underwritten with elevated interest rate floors in the 13% to 13.5% range to help mitigate potential declines in SOFR

    80% confidence
  • The 24-basis-point yield decline was broadly consistent with a 32-basis-point decline in SOFR during the quarter and was mitigated by interest rate floors embedded in each debt investment

    80% confidence
  • The company delivered a very strong performance in fiscal 2026 to date, driven by both portfolio expansion and results at existing portfolio companies

    80% confidence
  • Portfolio company valuations in the aggregate increased by $70.2 million of net unrealized appreciation, driven by improved performance at some portfolio companies and higher valuation multiples across the portfolio, partially offset by weaker performance elsewhere

    80% confidence
  • With over half of the debt portfolio currently at their floors, management believes portfolio yield is well protected against further rate declines

    80% confidence
  • The NAV increase was primarily driven by $1.77 per share of net unrealized appreciation and $0.09 per share of net realized gains, partially offset by $0.24 per share of distributions, $0.16 per share of net investment loss, and $0.03 per share of realized losses tied to the redemption of 8% notes

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com